-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UY7C0I9zTVsXRO+SXV+qK9+rFKM6QGHsgPTw/9IucUXRufKxzRXnKUkeTHxBf/Ui +Fb2tMyCzhIUZrFesXR6YA== 0000898430-96-004265.txt : 19960911 0000898430-96-004265.hdr.sgml : 19960911 ACCESSION NUMBER: 0000898430-96-004265 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960910 SROS: NASD GROUP MEMBERS: SSCO INC. GROUP MEMBERS: STROME MARK E GROUP MEMBERS: STROME SUSSKIND INVESTMENT MANAGEMENT LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE CENTRAL INDEX KEY: 0000094784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870277826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-07547 FILM NUMBER: 96627998 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO RD STREET 2: RESERVOIR PL CITY: WALTHAM STATE: MA ZIP: 02154 BUSINESS PHONE: 6178908263 MAIL ADDRESS: STREET 2: 1601 TRAPELO RD CITY: WALTHAN STATE: MA ZIP: 02154 FORMER COMPANY: FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE DATE OF NAME CHANGE: 19790521 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: STROME SUSSKIND INVESTMENT MANAGEMENT LP CENTRAL INDEX KEY: 0000936711 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 954450882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 100 WILSHIRE BLVD STREET 2: 15TH FLOOR CITY: SANTA MONICA STATE: CA ZIP: 90401 MAIL ADDRESS: STREET 1: 100 WILSHIRE BLVD STREET 2: 15TH FLOOR CITY: SANTA MONICA STATE: CA ZIP: 90401 SC 13G 1 SC13G - COMMON STOCK FILING FOR (3) ENTITIES --------------------------- OMB APPROVAL --------------------------- OMB number: 3235-0145 Expires: October 31, 1994 Estimated average burden hours per response... 14.90 --------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* ----- Boston Life Sciences, Inc. ------------------------------------------------------------- (Name of Issuer) Common Stock --------------------------------------------------- (Title of Class of Securities) 100843101 ----------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [X]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ----------------------- --------------------- CUSIP NO. 100843101 13G PAGE 2 OF 12 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Strome Susskind Investment Management, L.P. #95-4450882 - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 12,589,088 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 12,589,088 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 12,589,088 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 11.41 - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 PN, IA - ------------------------------------------------------------------------------ *SEE INSTRUCTION BEFORE FILLING OUT! - ----------------------- --------------------- CUSIP NO. 100843101 13G PAGE 3 OF 12 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON SSCO, Inc. #95-4450883 - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 12,589,088 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 12,589,088 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 12,589,088 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 11.41 - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 CO, HC - ------------------------------------------------------------------------------ *SEE INSTRUCTION BEFORE FILLING OUT! - ----------------------- --------------------- CUSIP NO. 100843101 13G PAGE 4 OF 12 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Mark E. Strome ####-##-#### - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 U.S. - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 12,589,088 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 12,589,088 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 12,589,088 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 11.41 - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 IN, HC - ------------------------------------------------------------------------------ *SEE INSTRUCTION BEFORE FILLING OUT! Page 5 of 12 Item 1 (a) Name of Issuer: Boston Life Sciences, Inc. Item 1 (b) Address of Issuer's Principal Executive Offices: 1601 Trapelo Road Waltham, MA 02154 Item 2 (a) Name of Person Filing: This statement is being filed by: a. Strome-Susskind Investment Management, L.P. ("SSIM") b. SSCO, Inc. ("SSCO"); and c. Mark E. Strome ("Strome") collectively the "Reporting Persons". SSIM is a Delaware limited partnership and a registered investment adviser. SSIM is the sole general partner of and investment adviser to two investment limited partnerships, and is also the investment adviser to two offshore investment corporations. The investment limited partnerships and the offshore investment corporations (collectively referred to hereinafter as the "Entities") have acquired 3,020,905 shares of the common stock of Boston Life Sciences, Inc. ("BLSI") and 47,751 shares of the preferred stock of BLSI. Each share of the BLSI preferred stock is presently convertible into 175.3771 shares of the BLSI common stock. The Entities also have the right to acquire 1,193,751 shares of the common stock of BLSI pursuant to certain warrants which are presently exercisable. Therefore, the Entities beneficially own 12,589,088 shares of the common stock (the "Stock") of BLSI (computed in accordance with Rule 13d-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended). Based upon information obtained from BLSI, as of the date hereof, the Entities beneficially own approximately 11.41% of the common stock of BLSI (similarly computed). SSCO is the sole general partner of SSIM. The Strome Family Trust, dated 12/9/93 (the "Trust") is the controlling shareholder of SSCO. Mark E. Strome is a settlor and trustee of the Trust. Page 6 of 12 SSIM's beneficial ownership of the Stock is direct because of its general partnership interest in each of the two investment limited partnerships that directly own shares of the Stock. SSIM also has direct beneficial ownership of the Stock as a result of its discretionary authority to buy, sell and vote shares of such Stock for its investment advisory clients (i.e., the two investment limited partnerships and the two investment corporations). SSCO's and Strome's beneficial ownership is indirect as a result of their ownership of SSIM, and is reported solely because Rule 13-d (a) and (b) under the Securities Exchange Act of 1934, as amended, requires any person who is "directly or indirectly" the beneficial owner of more than five percent of any equity security of a specific class to file a Schedule 13G within the specific time period. The answers on blocks 6, 8, 9 and 11 on pages 3 and 4 above and in responses to item 4 by SSCO and Strome are given on the basis of the "indirect" beneficial ownership referred to in such Rule, based on the direct beneficial ownership of the Stock by SSIM and the relationship of SSCO and Strome to SSIM. Information with respect to each Reporting Person is given solely by the respective Reporting Person, and no Reporting Person undertakes hereby any responsibility for the accuracy or completeness of such information concerning any other Reporting Person. Item 2 (b) Address of Principal Business office or, if none, residence of Reporting Person: a. 100 Wilshire Blvd., 15th Fl. Santa Monica, CA 90401 b. 100 Wilshire Blvd., 15th Fl. Santa Monica, CA 90401 c. 100 Wilshire Blvd., 15th Fl. Santa Monica, CA 90401 Item 2 (c) Citizenship: a. Strome-Susskind Investment Management, L.P.; Delaware limited partnership b. SSCO, Inc., Delaware corporation c. Mark E. Strome; United States Item 2 (d) Title of Class of Securities: Common Stock Page 7 of 12 Item 2 (e) CUSIP Number: 100843101 Item 3. Statement Concerning Filings Pursuant to Rule 13d-1(b) or 13d-2(b): (e) x Investment Adviser - (g) x Parent Holding Company [controlling shareholders] [See Item 7] - Item 4. Ownership: (a) Amount Beneficially Owned: Reporting Persons each directly or indirectly beneficially own 12,589,088 shares of Stock. SSIM's beneficial ownership is direct and SSCO's and Strome's beneficial ownership is indirect. (b) Percent of Class: 11.41% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: The Reporting Persons share with each other the power to vote all 12,589,088 shares of Stock for which they have direct or indirect beneficial ownership. No other person has the power to vote such shares. (iii) sole power to dispose or to direct the disposition of : 0 (iv) shared power to dispose or to direct the disposition of: The Reporting Persons share with each other the power to dispose of all 12,589,088 shares for which they have direct or indirect beneficial ownership. They do not share this power with any other person. Item 5. Ownership of Five Percent or Less of a Class: Not Applicable Page 8 of 12 Item 6. Ownership of More than Five Percent on Behalf of Another Person: SSIM, a registered investment adviser, SSCO, its general partner and Strome, the trustee of SSCO's controlling shareholder, have the right or the power to direct the receipt of dividends from the Stock, and to direct the receipt of proceeds from the sale of Stock to SSIM's investment advisory clients. No single investment advisory client of SSIM owns more than 5% of the Stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. SSCO and Strome are each considered the equivalent of a parent holding company for purposes of this Schedule 13G. SSIM, a registered investment adviser, is considered SSCO's and Strome's subsidiary. See Exhibit B. Item 8. Identification and Classification of Members of the Group: Not Applicable Item 9. Notice of Dissolution of Group: Not Applicable Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. Page 9 of 12 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. /s/ Mark E. Strome ------------------------------ Mark E. Strome STROME SUSSKIND INVESTMENT MANAGEMENT, L.P. By SSCO, Inc., its General Partner By:/s/ Mark E. Strome --------------------------- Mark E. Strome, President SSCO, INC. By:/s/ Mark E. Strome --------------------------- Mark E. Strome, President Date: 9/5/96 ---------------------- Page 10 of 12 EXHIBITS EXHIBIT A Statement With Respect to Joint Filing of Schedule 13G EXHIBIT B Identification and Classification of Subsidiary Which Acquired Security Being Reported On By the Parent Holding Company Page 11 of 12 EXHIBIT A JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(f)(1) --------------------------------------------------- This agreement is made pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934 (the "Act") by and among the parties listed below, each referred to herein as a "Joint Filer." The Joint Filers agree that a statement of beneficial ownership as required by Section 13(d) of the Act and the Rules thereunder may be filed on each of their behalf on Schedule 13D or Schedule 13G, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers states that they each satisfy the requirements for making a joint filing under Rule 13d-1. Dated: September 5, 1996 /s/ Mark E. Strome - ---------------------------- Mark E. Strome STROME SUSSKIND INVESTMENT MANAGEMENT, L.P. By SSCO, Inc., its General Partner By:/s/ Mark E. Strome ------------------------- Mark E. Strome, President SSCO, INC. By:/s/ Mark E. Strome ------------------------- Mark E. Strome, President Page 12 of 12 EXHIBIT B Identification and Classification of Subsidiary Which Acquired Security Being Reported On By the Parent Holding Company SSIM, a registered investment adviser, acquired "beneficial ownership" of the securities being reported on as a result of its discretionary authority to acquire, dispose and (with respect to certain of such securities) vote the securities being reported on. Under a series of SEC no-action letters, including the letter issued to Warren Buffet and Berkshire Hathaway, Inc. (available December 18, 1987), SSCO and Strome are each considered the equivalent of a parent holding company of SSIM and are therefore eligible to report their indirect beneficial ownership in such shares on Schedule 13G. -----END PRIVACY-ENHANCED MESSAGE-----